Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D565H vs D565 in Glaucoma and Ocular Hypertension
NCT03067415Phase 2Unknown
- Sponsor
- Chong Kun Dang Holdings
- Start
- Mar 2017
- Primary completion
- Sep 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of latanoprost in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Chong Kun Dang Holdings. Status: unknown.
02
Drugs
latanoprost
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT03067415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03067415.